Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers
Clinical trial NCT01563302 · COMPLETED
Trial details
- NCT number
- NCT01563302
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-27
- Primary completion
- 2016-03-23
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.